NIT-OCCLUD PDA Phase II Sentinel Trial
Public ClinicalTrials.gov record NCT00828334. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Transcatheter Occlusion of Patent Ductus Arteriosus (PDA) With the NIT-OCCLUD PDA Occlusions System
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety and efficacy of the Nit-Occlud -PDA Occlusion System for transcatheter closure of PDA with minimum angiographic diameter less than 4 mm, and to compare one year safety and efficacy outcomes with recommended OPCs.
Study identification
- NCT ID
- NCT00828334
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 357 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 6 Months to 21 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2002 (Type not available)
- Primary completion
- Jun 2007 (Actual)
- Completion
- Oct 2007 (Actual)
- Last update posted
- Mar 23, 2018
2002 – 2007
United States locations
- U.S. sites
- 15
- U.S. states
- 10
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mattel Children's Hospital at UCLA | Los Angeles | California | 90095 | — |
| Children's Hospital Central California | Madera | California | 93638 | — |
| Children's Hospital of Orange County | Orange | California | 92868 | — |
| A.I. Dupont Hospital for Children | Wilmington | Delaware | 19899 | — |
| Children's National Medical Center | Washington D.C. | District of Columbia | 20010 | — |
| Hope Children's Hospital | Oak Lawn | Illinois | 60453 | — |
| Children's Hospital of Illinois | Peoria | Illinois | 61603 | — |
| Riley Hospital for Children | Indianapolis | Indiana | 46202-5225 | — |
| Children's Hospital of Iowa | Iowa City | Iowa | 52242 | — |
| Children's Hospital of Akron | Akron | Ohio | 44308 | — |
| Columbus Children's Hospital | Columbus | Ohio | 43205 | — |
| St. Christopher's Hospital for Children | Philadelphia | Pennsylvania | 19134 | — |
| Driscoll Children's Hospital | Corpus Christi | Texas | 78411 | — |
| Children's Medical Center of Dallas | Dallas | Texas | 75235 | — |
| Children's Hospital and Regional Medical Center Seattle | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00828334, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 23, 2018 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00828334 live on ClinicalTrials.gov.